MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

186.02
+1.26
+0.68%
After Hours: 186.02 0 0.00% 16:21 09/17 EDT
OPEN
186.04
PREV CLOSE
184.76
HIGH
186.60
LOW
182.94
VOLUME
351.95K
TURNOVER
--
52 WEEK HIGH
198.03
52 WEEK LOW
105.48
MARKET CAP
6.66B
P/E (TTM)
40.11
1D
5D
1M
3M
1Y
5Y
Why Medpace Holdings, Inc. (NASDAQ:MEDP) Could Be Worth Watching
Medpace Holdings, Inc. ( NASDAQ:MEDP ), might not be a large cap stock, but it saw significant share price movement...
Simply Wall St. · 1d ago
Medpace Hldgs Insider Trades $12 Million In Company Stock
Susan E Burwig, Exec. Vp And Operations at Medpace Hldgs (NASDAQ:MEDP), made a large insider sell on September 3, according to a new SEC filing.
Benzinga · 09/08 21:49
Insider Sell: Medpace Holdings
MT Newswires · 09/07 16:45
Medpace Holdings Inc (MEDP) CEO August J. Troendle Sold $5.9 million of Shares
GuruFocus News · 09/07 09:26
Medpace Holdings Inc (MEDP) CEO August J. Troendle Sold $5 million of Shares
GuruFocus News · 09/03 14:15
Medpace (MEDP) Moves 3.3% Higher: Will This Strength Last?
Medpace (MEDP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks · 09/03 11:39
Medpace Stock Earns Relative Strength Rating Upgrade; Remains In Buy Zone
marketwatch.com · 09/02 21:28
Medpace Holdings Inc (MEDP) CEO August J. Troendle Sold $4.4 million of Shares
GuruFocus News · 09/01 02:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MEDP. Analyze the recent business situations of Medpace Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MEDP stock price target is 182.00 with a high estimate of 205.00 and a low estimate of 165.00.
EPS
Institutional Holdings
Institutions: 435
Institutional Holdings: 30.27M
% Owned: 84.50%
Shares Outstanding: 35.82M
TypeInstitutionsShares
Increased
111
1.20M
New
28
400.61K
Decreased
126
1.81M
Sold Out
22
115.71K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.49%
Pharmaceuticals & Medical Research
-0.10%
Key Executives
Chairman/Chief Executive Officer/Director
August Troendle
President
Jesse Geiger
Chief Financial Officer
Kevin Brady
Executive Vice President
Susan Burwig
General Counsel/Secretary
Stephen Ewald
Lead Director/Independent Director
Fred Davenport
Independent Director
Brian Carley
Independent Director
Ashley Keating
Independent Director
Thomas King
Independent Director
Robert Kraft
Independent Director
Cornelius McCarthy
No Data
About MEDP
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers kinds of Medpace Holdings Inc stock information, including NASDAQ:MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.